Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H21N3O2 |
Molecular Weight | 275.3461 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12N(C)CC[C@@]1(C)C3=C(C=CC(OC(=O)NC)=C3)N2C
InChI
InChIKey=PIJVFDBKTWXHHD-HIFRSBDPSA-N
InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1
Molecular Formula | C15H21N3O2 |
Molecular Weight | 275.3461 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:04 UTC 2023
by
admin
on
Fri Dec 15 15:01:04 UTC 2023
|
Record UNII |
9U1VM840SP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QS01EB05
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
WHO-ATC |
S01EB05
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
NCI_THESAURUS |
C47792
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
WHO-VATC |
QA03FA90
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
WHO-VATC |
QA03AX90
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
WHO-VATC |
QV03AB19
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
LIVERTOX |
776
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
||
|
WHO-ATC |
V03AB19
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3161
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
9U1VM840SP
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
27953
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
100000079444
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
9U1VM840SP
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
DTXSID3023471
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
57-47-6
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
D010830
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
6598
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
Physostigmine
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
2159
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL94
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
m8766
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
5983
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
PHYSOSTIGMINE
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
30782
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
200-332-8
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
8299
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00981
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
SUB14864MIG
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY | |||
|
C81337
Created by
admin on Fri Dec 15 15:01:04 UTC 2023 , Edited by admin on Fri Dec 15 15:01:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|